Quadrant Capital Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,192
Closed -$100K 2297
2026
Q1
$100K Buy
3,192
+1,362
+74% +$42.9K ﹤0.01% 1481
2025
Q4
$53.9K Buy
1,830
+235
+15% +$6.53K ﹤0.01% 1658
2025
Q3
$40.3K Buy
+1,595
New +$38.9K ﹤0.01% 1746
2025
Q2
Sell
-535
Closed -$12.3K 2345
2025
Q1
$12.3K Sell
535
-2,043
-79% -$49.3K ﹤0.01% 2169
2024
Q4
$65.3K Sell
2,578
-2,051
-44% -$52K ﹤0.01% 1274
2024
Q3
$115K Sell
4,629
-884
-16% -$26.2K 0.01% 992
2024
Q2
$163K Buy
5,513
+1,417
+35% +$39.3K 0.01% 750
2024
Q1
$123K Buy
4,096
+73
+2% +$2.03K 0.01% 888
2023
Q4
$115K Buy
4,023
+278
+7% +$8.16K 0.01% 914
2023
Q3
$139K Sell
3,745
-39
-1% -$1.49K 0.01% 698
2023
Q2
$148K Buy
3,784
+80
+2% +$3.13K 0.01% 659
2023
Q1
$135K Buy
3,704
+496
+15% +$15.7K 0.01% 677
2022
Q4
$98.8K Buy
+3,208
New +$99.6K 0.01% 778

Other funds holding RTO

Quadrant Capital Group's RTO Position: Q2 2026 in Review

Quadrant Capital Group sold out of Rentokil (RTO) in Q2 2026, closing a stake of 3,192 shares — an estimated $100K sold.

Quadrant Capital Group first reported a position in RTO in Q4 2022 and held it in 13 quarters. The position peaked at $163K in Q2 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Quadrant Capital Group reported no remaining Rentokil position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 3,192 Rentokil shares in Q2 2026, an estimated $100K.
  • Quadrant Capital Group first reported a position in Rentokil in Q4 2022 and held it in 13 quarters.
  • Quadrant Capital Group's Rentokil position peaked at $163K in Q2 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.